These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29511881)

  • 1. Optimal time of resuming anticoagulant after endoscopic sphincterotomy in patients at risk for thromboembolism: a retrospective cohort study.
    Paik WH; Lee SH; Ahn DW; Jeong JB; Kang JW; Son JH; Ryu JK; Kim YT
    Surg Endosc; 2018 Sep; 32(9):3902-3908. PubMed ID: 29511881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of anticoagulants and risk factors for bleeding following endoscopic sphincterotomy among anticoagulant users: Results from a large multicenter retrospective study.
    Muro S; Kato H; Ishida E; Ueki T; Fujii M; Harada R; Seki H; Hirao K; Wato M; Akimoto Y; Takatani M; Tsugeno H; Miyaike J; Toyokawa T; Nishimura M; Yunoki N; Okada H
    J Gastroenterol Hepatol; 2020 Jan; 35(1):37-42. PubMed ID: 31237013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
    Nagata N; Sakurai T; Moriyasu S; Shimbo T; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
    PLoS One; 2017; 12(9):e0183423. PubMed ID: 28863196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-polypectomy bleeding and thromboembolism risks associated with warfarin
    Yanagisawa N; Nagata N; Watanabe K; Iida T; Hamada M; Kobayashi S; Shimbo T; Akiyama J; Uemura N
    World J Gastroenterol; 2018 Apr; 24(14):1540-1549. PubMed ID: 29662292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants increase bleeding risk after endoscopic sphincterotomy: a retrospective study.
    Masuda S; Koizumi K; Nishino T; Tazawa T; Kimura K; Tasaki J; Ichita C; Sasaki A; Kako M; Uojima H; Sugitani A
    BMC Gastroenterol; 2021 Oct; 21(1):401. PubMed ID: 34689751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
    Santos CD; Matos NL; Asleh R; Dawit S; Rabinstein AA; O'Carroll CB; Li Z; Freeman WD
    Neurocrit Care; 2020 Jun; 32(3):822-827. PubMed ID: 31531758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
    Witt DM; Delate T; Garcia DA; Clark NP; Hylek EM; Ageno W; Dentali F; Crowther MA
    Arch Intern Med; 2012 Oct; 172(19):1484-91. PubMed ID: 22987143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resumption of anticoagulant therapy after major bleeding and recurrence of hemorrhagic complications in patients with atrial fibrillation with a high risk of stroke and thromboembolism (based on the results of 20 years of observation)].
    Mironova Staroverova AI; Panchenko EP; Kropacheva ES; Zemlyanskaya OA
    Ter Arkh; 2020 Oct; 92(9):15-23. PubMed ID: 33346426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with delayed hemorrhage after endoscopic sphincterotomy: Japanese large single-center experience.
    Ikarashi S; Katanuma A; Kin T; Takahashi K; Yane K; Sano I; Yamazaki H; Maguchi H
    J Gastroenterol; 2017 Dec; 52(12):1258-1265. PubMed ID: 28478523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis.
    Nagata N; Yasunaga H; Matsui H; Fushimi K; Watanabe K; Akiyama J; Uemura N; Niikura R
    Gut; 2018 Oct; 67(10):1805-1812. PubMed ID: 28874418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of delayed hemorrhage after endoscopic sphincterotomy.
    Kim KO; Kim TN; Kim SB; Lee JY
    J Gastroenterol Hepatol; 2010 Mar; 25(3):532-8. PubMed ID: 20074163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case-control study.
    So S; Ahn JY; Kim N; Na HK; Jung KW; Lee JH; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY
    Gastrointest Endosc; 2019 Feb; 89(2):277-285.e2. PubMed ID: 30145315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study.
    Eljilany I; Elarref M; Shallik N; Elzouki AN; Mohammed A; Shoman B; Ibrahim S; Carr C; Al-Badriyeh D; Cavallari LH; Elewa H
    Curr Probl Cardiol; 2021 Jun; 46(6):100816. PubMed ID: 33721568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves.
    Sakusic A; Rabinstein AA; Anisetti B; Mandrekar J; Wijdicks EFM; Freeman WD; Braksick SA
    Neurology; 2024 Aug; 103(4):e209664. PubMed ID: 39102615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of post-sphincterotomy bleeding with antiplatelet and anticoagulant use: a propensity-matched analysis of the U.S. Collaborative Network.
    Chandan S; Desai A; Dahiya DS; Ramai D; Mohan BP; Facciorusso A; Adler DG; Kochhar GS
    Gastrointest Endosc; 2023 Jun; 97(6):1129-1136.e3. PubMed ID: 36731579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.